Glaxosmithkline | GSK - Interest Income


Glaxosmithkline reported GBP26M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
AstraZeneca USD 85M 17M Sep/2025
Aurora Cannabis CAD 1.85M 120K Sep/2025
Bausch Health Companies USD 15M 2M Sep/2025
Corcept Therapeutics USD 5.02M 7K Sep/2025
Drreddys Laboratories INR 796M 332M Dec/2025
Eli Lilly USD 65M 25M Sep/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Glaxosmithkline GBP 26M 24M Sep/2025
J&J USD 2.12 0.17 Sep/2025
Merck USD 96M 27M Sep/2025
Pacira USD 8.53M 3.53M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Phibro Animal Health USD 0.08 0.09 Dec/2024
Sanofi EUR 114M 38M Sep/2025
Supernus Pharmaceuticals USD 2.28M 2.25M Sep/2025
Takeda JPY 87.87B 43.48B Dec/2025
Zoetis USD 26M 7M Sep/2025